GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Current Deferred Revenue

Abbisko Cayman (STU:8ZD) Current Deferred Revenue : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Abbisko Cayman's current deferred revenue for the quarter that ended in Dec. 2023 was €0.00 Mil.

Abbisko Cayman Current Deferred Revenue Historical Data

The historical data trend for Abbisko Cayman's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Current Deferred Revenue Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
- - - - -

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial - - - - -

Abbisko Cayman Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbisko Cayman (STU:8ZD) Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines